Evaluating Efficacy and Safety of Tisagenlecleucel Reinfusion Following Loss of B-Cell Aplasia in Pediatric and Young Adult Patients with Acute Lymphoblastic Leukemia: HESTER Phase II Study
Michael W. Boyer(University of Utah), Jennifer Willert(Unknown), Samuel John(Southwestern Medical Center), Andrea Magley, Amy K. Keating(Boston Children's Hospital), Christina Kovacs, Sonali Chaudhury(Northwestern University), Stephan A. Grupp(Children's Hospital of Philadelphia), Julie-An Talano(Medical College of Wisconsin), Mike A. Pulsipher(Primary Children's Hospital), Olufolake Adisa, Timothy A. Driscoll(Duke Medical Center), Christine L. Phillips(Cincinnati Children's Hospital Medical Center), Gary D. Myers(Children's Mercy Hospital), Michelle L. Hermiston(VinUniversity), Das Purkayastha, Kara L. Davis(Stanford Medicine)
Cited by 0
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k